Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
Crossref DOI link: https://doi.org/10.1186/s12888-020-02965-7
Published Online: 2020-12-22
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iwanami, Akira
Saito, Kazuhiko
Fujiwara, Masakazu
Okutsu, Daiki
Ichikawa, Hironobu
Text and Data Mining valid from 2020-12-01
Version of Record valid from 2020-12-22
Article History
First Online: 22 December 2020